Snowball logo
logo
23I

Intra-Cellular Therapies Inc

122.000.00  (0%)

Frequently asked questions

What sector does Intra-Cellular Therapies Inc (23I) operate in?

Intra-Cellular Therapies Inc belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Intra-Cellular Therapies Inc (23I) current stock price?

As of the latest data, Intra-Cellular Therapies Inc stock price is €122.00, with a previous close of €122.00.

What is Intra-Cellular Therapies Inc (23I) current market capitalization?

Intra-Cellular Therapies Inc market cap is approximately 13.00 billion.

What is Intra-Cellular Therapies Inc (23I) Earnings Per Share (EPS)?

The trailing EPS is -€0.67.

Does Intra-Cellular Therapies Inc (23I) pay dividends?

No. Intra-Cellular Therapies Inc does not pay a dividend.

What is Intra-Cellular Therapies Inc (23I) beta (volatility) score?

Intra-Cellular Therapies Inc has a beta of 0.462, indicating lower volatility than the overall market.